Myriad Proteomics is the proteomics subsidiary of Myriad Genetics

History:

Formed as a joint venture among Myriad Genetics, Hitachi and Oracle in 2001. In 2003 they changed their name to Prolexys Pharmaceuticals.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northern California

Research Focus:
Proteomics

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: